top of page
Behavioral aspects and neurobiological properties underlying medical cannabis treatment in the Shank3 mouse model of autism spectrum disorder. Shani Poleg et al. Translational Psychiatry volume 11, Article number: 524 (2021)
New insight into how cannabidiol takes effect in the brains of people with psychosis
KGL, January 20, 2020
Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsy
Epilepsy Behav. 2019 Aug;97:105-110.
Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities
Front. Pharmacol., 09 January 2019
Real life experience of medical cannabis treatment in autism: analysis of safety and efficacy
Scientific Reports volume 9, article number: 9 b-136bad5cf58d_200 (2019)
Plasma Anandamide Concentrations are Lower in Children with Autism Spectrum Disorder
Karhson et al. Molecular Autism (2018) 9:18
Cannabinoids in Pediatrics
The Journal of Pediatric Pharmacology and Therapeutics, 2017 May-Jun; 22(3): 176–185
Endocannabinoid Signal Dysregulation in Autism Spectrum Disorders: A Correlation Linkbetween Inflammatory State and Neuro-Immune Alterations
International Journal of Molecular Sciences, 3 July 2017
Evidence for a Common Endocannabinoid-Related Pathomechanism in Autism Spectrum Disorders
Neuron, Volume 78, Issue 3, 8 May 2013, Pages 408-410
bottom of page